Solid Biosciences Inc.
SLDB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $583 | $458 | $245 | $163 |
| - Cash | $61 | $139 | $211 | $80 |
| + Debt | $22 | $23 | $24 | $24 |
| Enterprise Value | $543 | $343 | $58 | $107 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$45 | -$39 | -$39 | -$42 |
| % Margin | – | – | – | – |
| Net Income | -$46 | -$39 | -$39 | -$43 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.48 | -0.42 | -0.59 | -0.8 |
| % Growth | -14.3% | 28.8% | 26.3% | – |
| Operating Cash Flow | -$33 | -$37 | -$32 | -$30 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$34 | -$38 | -$32 | -$30 |